Search results
Results from the WOW.Com Content Network
Selamectin, sold under the brand name Revolution, among others, is a topical parasiticide and anthelminthic used on dogs and cats. [2] It treats and prevents infections of heartworms, fleas, ear mites, sarcoptic mange (scabies), and certain types of ticks in dogs, and prevents heartworms, fleas, ear mites, hookworms, and roundworms in cats.
Polyprenyl immunostimulant is the only currently-approved treatment in the US for feline rhinotracheitis caused by herpesvirus. [11] Effectiveness was demonstrated in a clinical study with cats experimentally infected with feline herpesvirus: 20 cats were treated with polyprenyl immunostimulant and 20 received a placebo.
Feline disease refers to infections or illnesses that affect cats. They may cause symptoms, sickness or the death of the animal. Some diseases are symptomatic in one cat but asymptomatic in others. Feline diseases are often opportunistic and tend to be more serious in cats that already have concurrent sicknesses.
Flea & Tick Spot Treatment for Cats Over 1.5 lbs. This spot treatment for cats kills fleas, flea eggs, larvae, ticks, and lice. It comes with an applicator that makes it easy to apply the topical ...
Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
The post Lentigo in Cats: Symptoms, Causes, & Treatments appeared first on CatTime. Lentigo in cats is a common dermatological condition characterized by the presence of small, flat, brownish ...
A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, there are no proven ...
In spite of Pfizer's list price of US$1,390 for five days in the US, treatment has been and will be free through the end of 2024 for Medicare or Medicaid beneficiaries and insured persons covering out-of-pocket costs. [29] [79] Pfizer reported revenue of US$1.279 billion for Paxlovid in 2023. [80]